Your SlideShare is downloading. ×
Cell phone enabled diagnostics m health applications in ivd
Cell phone enabled diagnostics m health applications in ivd
Cell phone enabled diagnostics m health applications in ivd
Cell phone enabled diagnostics m health applications in ivd
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Cell phone enabled diagnostics m health applications in ivd

195

Published on

The report looks at the entire pipeline to 2015, a key focus of the report is the increasing role of biopharmaceutical products. The growing interest in biotechnology development has transitioned the …

The report looks at the entire pipeline to 2015, a key focus of the report is the increasing role of biopharmaceutical products. The growing interest in biotechnology development has transitioned the pharmaceutical industry to biopharmaceuticals in less than a decade.

Published in: Technology, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
195
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Cell Phone-Enabled Diagnostics: mHealthApplications in IVDMobile health has reached in vitro diagnostics and as this Kalorama report details, may change theindustry forever. Over the years, the introduction of transportable, portable, and handheld instrumentshas resulted in the migration of clinical lab testing from the central lab to a range of environmentsincluding self-testing, community clinics, the workplace, home, disaster care and most recently, retailconvenience clinics. In spite of promotional materials that emphasize ease of use, the majority ofcurrently available POC tests require a fair amount of medical lab know-how, especially in theinterpretation of the test result.The goal is for cell phone-enabled test devices to provide primary care for underserved areas indeveloped countries and low income developing markets. Especially since new technologies are allowingPOC devices to produce quantitative lab-quality test results that can be transferred automatically to aninformation system, to a remote caregiver service for consultation or to an electronic medical record.Get your copy of this report @ http://www.reportsnreports.com/reports/190904-cell-phone-enabled-diagnostics-mhealth-applications-in-ivd.htmlReport Details:Published: August 2012No. of Pages: 130Price: Single User License – US$2500 Corporate User License – US$5000This report, Cell Phone-Enabled Diagnostics: mHealth Applications in IVD tracks cell phone-enabledproducts on the market and how they will affect the existing diagnostic industry. As part of this reportscoverage, the following is included:Representative Cell Phone-Enabled Products in Diabetes, Immunoassays, Hematology, Histology andMolecular IVD.  Market Outlook for mHealth In IVD and The Best Areas For Commercial Success  Description of the Market Leaders, Organizations and Companies In This Market.  Government and Payer Support for mHealth  The Role of New technologies in the Evolution of POCT  Consumer, Physician and Payor Willingness  How Upstarts are Faring Vs. Established Products
  • 2.  Analyst ConclusionsKalorama lead diagnostic analyst Shara Rosen, R.T., MBA presents the new developments in theconvergence of IVD and mobile technologies in this unique overview of the mHealth IVD market. Thecompany profile chapter provides a selection of companies and organizations that are pioneering the useof specially designed digital and or wireless and cell phone-enabled test devices for clinical diagnosticapplications. The most advanced applications are available for glucose self-testing and the transmissionof stained slide images in histology, microbiology and hematology for remote consultation with andanalysis by an expert. The following companies are profiled.  Accuster Technologies Pvt. Ltd.  AgaMatrix, Inc.  Alere  ARKRAY  ARUP Laboratories  Axxin  BBInternational  BIO-key International, Inc.  BodyTel Europe GmbH  California Institute of Technology (Caltech)  CellScope  CellScope Inc.  Clearbridge BioLoc Pte Ltd  Columbia University  DNAFORM  eSTI – (Electronic self-testing instruments)  Entra Health Systems  Freescale Semiconductor  Bill and Melinda Gates Foundation  Gene-Z  Genomic Health, Inc.  GenPrime, Inc.  Gentag Inc.  GlySens Incorporated  Harvard University Medical School  Heidelberger-Medical-Marketing GmbH (HMM GmbH)  HolGenTech Inc.  Holomic LLC (formerly Microskia)  Infopia Co Ltd
  • 3.  Intelligent Optical Systems, Inc.  Korea Advanced Institute of Science of Technology (KAIST)  Labonfoil Consortium  Leica Microsystems  Lifescan Inc.  Massachusetts General Hospital  MAVAND Solutions GmbH  MEDIWISS Analytic GmbH  Medtronic Inc.  MycroLab Pty Ltd.  NextLab  Oasis Diagnostics  Oasis Scientific, Inc.  QIAGEN N.V.  QuantuMDx Group Limited  Sano Intelligence  Skannex  TelCare Inc.  Università Commerciale Luigi Bocconi  University of Arizona  University of Washington  X out TBThe companies selected are those that are pioneers in their field and that provide an overview of theinnovations underway in cell phone-enabled diagnostics. The information presented in this report isderived on publicly available information sources such as company, government, and medicalorganization reports. The analysis is based on the authors industry knowledge combined with literaturesearches and interviews with industry professionals and experts in the areas of POC tests, mobile health,decentralized healthcare and healthcare economics.The use of cell phone-enabled diagnostics is in the earlystages of development in both developed anddeveloping world markets. Thereforethis market analysis is somewhat speculative.In spite of the buzzabout the use of cell phone-enabled test devices inmHealth, there are so many combinations of devices,applications and marketsthat the market is hard to define with precision.Current mHealth programs that use cell phones as part of thediagnostic process (with the exception ofglucose self-testing) have beeninitiated as pilot projects in developing countries with little or noconcreteplans for their continuation as fully funded and government supportedhealthcare services.
  • 4. Further, since much of the current mHealth products aredelivered as smartphone apps and services thatare offered as part of a productoffering, it is difficult to estimate the size of the opportunity. Nevertheless,this report takes a bold lookinto the possibilities for cell phone-enabled testing in the next five to tenyears.Explore more reports on Healthcare @ http://www.reportsnreports.com/market-research/healthcare/Contact:TX, Dallas North - Dominion Plaza,17304, Preston Road,Suite 800, Dallas 75252.+ 1 888 391 5441sales@reportsandreports.comConnect With Us:

×